We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Mogrify Awarded $555,000 USD (£420,000 GBP) Innovate UK Funding to Accelerate Regenerative Cell Therapies

Product News   Mar 19, 2019

 
Mogrify Awarded $555,000 USD (£420,000 GBP) Innovate UK Funding to Accelerate Regenerative Cell Therapies

Dr. Darrin M. Disley, OBE, CEO, Mogrify

FURTHER INFORMATION
 
 
 

Related Product News

“Automation For All” At ELRIG Drug Discovery 2019

Product News

Peak Analysis & Automation will showcase how automation can be used to enhance research at the upcoming ELRIG Drug Discovery 2019.

READ MORE

Adaptate Biotherapeutics Formed To Develop T-cell Modulating Antibody-based Therapies

Product News

A new company aims to modulate γd T-cell activity using therapeutic antibodies, with the potential to trigger an immune response against cancer.

READ MORE

Improving Reporter Gene Assays

Product News

AMSBIO has announced two new Luciferase assay kits designed to help improve gene reporter assays.

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Diagnostics Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE